Annual Total Expenses
$1.43 B
+$111.30 M+8.44%
December 31, 2023
Summary
- As of February 26, 2025, IART annual total expenses is $1.43 billion, with the most recent change of +$111.30 million (+8.44%) on December 31, 2023.
- During the last 3 years, IART annual total expenses has risen by +$209.55 million (+17.17%).
- IART annual total expenses is now at all-time high.
Performance
IART Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$388.98 M
-$32.22 M-7.65%
September 30, 2024
Summary
- As of February 26, 2025, IART quarterly total expenses is $388.98 million, with the most recent change of -$32.22 million (-7.65%) on September 30, 2024.
- Over the past year, IART quarterly total expenses has increased by +$33.16 million (+9.32%).
- IART quarterly total expenses is now -7.65% below its all-time high of $421.20 million, reached on June 30, 2024.
Performance
IART Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
IART Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.4% | +9.3% |
| 3 y3 years | +17.2% | +9.3% |
| 5 y5 years | +5.0% | +9.3% |
IART Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8.4% | -7.7% | +21.5% |
| 5 y | 5-year | at high | +17.2% | -7.7% | +59.0% |
| alltime | all time | at high | +8727.5% | -7.7% | +9624.6% |
Integra LifeSciences Holdings Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $388.98 M(-7.6%) |
| Jun 2024 | - | $421.20 M(+15.4%) |
| Mar 2024 | - | $364.91 M(+1.1%) |
| Dec 2023 | $1.43 B(+8.4%) | $360.99 M(+1.5%) |
| Sep 2023 | - | $355.83 M(-3.5%) |
| Jun 2023 | - | $368.76 M(+7.1%) |
| Mar 2023 | - | $344.46 M(+4.3%) |
| Dec 2022 | $1.32 B(-2.0%) | $330.18 M(+3.1%) |
| Sep 2022 | - | $320.14 M(-5.3%) |
| Jun 2022 | - | $337.95 M(+2.3%) |
| Mar 2022 | - | $330.47 M(-4.8%) |
| Dec 2021 | $1.35 B(+10.2%) | $347.30 M(+5.1%) |
| Sep 2021 | - | $330.42 M(-2.3%) |
| Jun 2021 | - | $338.14 M(+2.7%) |
| Mar 2021 | - | $329.36 M(-2.0%) |
| Dec 2020 | $1.22 B(-10.2%) | $336.00 M(+7.5%) |
| Sep 2020 | - | $312.69 M(+27.8%) |
| Jun 2020 | - | $244.59 M(-25.3%) |
| Mar 2020 | - | $327.22 M(-7.6%) |
| Dec 2019 | $1.36 B(-0.2%) | $354.02 M(+4.2%) |
| Sep 2019 | - | $339.79 M(+0.6%) |
| Jun 2019 | - | $337.69 M(+3.1%) |
| Mar 2019 | - | $327.38 M(-6.2%) |
| Dec 2018 | $1.36 B(+19.1%) | $349.21 M(+2.1%) |
| Sep 2018 | - | $342.18 M(+1.1%) |
| Jun 2018 | - | $338.56 M(+2.1%) |
| Mar 2018 | - | $331.50 M(-8.3%) |
| Dec 2017 | $1.14 B(+30.4%) | $361.38 M(+34.7%) |
| Sep 2017 | - | $268.19 M(+1.1%) |
| Jun 2017 | - | $265.18 M(+6.6%) |
| Mar 2017 | - | $248.68 M(+15.7%) |
| Dec 2016 | $876.74 M(+9.2%) | $214.89 M(-2.4%) |
| Sep 2016 | - | $220.24 M(-3.0%) |
| Jun 2016 | - | $226.93 M(+5.7%) |
| Mar 2016 | - | $214.67 M(-1.1%) |
| Dec 2015 | $803.15 M(+10.2%) | $217.15 M(+0.4%) |
| Sep 2015 | - | $216.37 M(+14.9%) |
| Jun 2015 | - | $188.33 M(+3.9%) |
| Mar 2015 | - | $181.29 M(-4.3%) |
| Dec 2014 | $728.86 M(+10.2%) | $189.49 M(+5.0%) |
| Sep 2014 | - | $180.42 M(-17.6%) |
| Jun 2014 | - | $218.96 M(+6.1%) |
| Mar 2014 | - | $206.32 M(+217.5%) |
| Dec 2013 | $661.46 M(-12.6%) | $64.98 M(-67.1%) |
| Sep 2013 | - | $197.65 M(-1.2%) |
| Jun 2013 | - | $199.99 M(+0.6%) |
| Mar 2013 | - | $198.84 M(+1.5%) |
| Dec 2012 | $757.09 M(+4.4%) | $195.87 M(+2.9%) |
| Sep 2012 | - | $190.35 M(-0.9%) |
| Jun 2012 | - | $192.15 M(+7.5%) |
| Mar 2012 | - | $178.72 M(-8.7%) |
| Dec 2011 | $725.17 M(+14.5%) | $195.77 M(+6.5%) |
| Sep 2011 | - | $183.89 M(-0.8%) |
| Jun 2011 | - | $185.33 M(+15.7%) |
| Mar 2011 | - | $160.17 M(-5.8%) |
| Dec 2010 | $633.37 M | $169.97 M(+6.7%) |
| Sep 2010 | - | $159.33 M(+3.5%) |
| Jun 2010 | - | $154.02 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $150.06 M(-3.6%) |
| Dec 2009 | $584.66 M(-3.7%) | $155.68 M(+4.9%) |
| Sep 2009 | - | $148.47 M(+4.7%) |
| Jun 2009 | - | $141.82 M(+2.3%) |
| Mar 2009 | - | $138.70 M(-7.2%) |
| Dec 2008 | $607.19 M(+25.7%) | $149.40 M(-21.3%) |
| Sep 2008 | - | $189.92 M(+43.4%) |
| Jun 2008 | - | $132.40 M(-2.3%) |
| Mar 2008 | - | $135.47 M(-4.7%) |
| Dec 2007 | $483.17 M(+34.0%) | $142.09 M(+21.8%) |
| Sep 2007 | - | $116.68 M(-1.0%) |
| Jun 2007 | - | $117.87 M(+10.6%) |
| Mar 2007 | - | $106.53 M(+1.2%) |
| Dec 2006 | $360.55 M(+62.5%) | $105.25 M(+0.4%) |
| Sep 2006 | - | $104.83 M(+20.5%) |
| Jun 2006 | - | $86.96 M(+36.9%) |
| Mar 2006 | - | $63.51 M(+9.4%) |
| Dec 2005 | $221.83 M(+8.2%) | $58.07 M(+9.1%) |
| Sep 2005 | - | $53.24 M(-7.6%) |
| Jun 2005 | - | $57.63 M(+9.0%) |
| Mar 2005 | - | $52.88 M(+9.8%) |
| Dec 2004 | $205.05 M(+40.5%) | $48.18 M(-32.4%) |
| Sep 2004 | - | $71.31 M(+59.0%) |
| Jun 2004 | - | $44.84 M(+10.1%) |
| Mar 2004 | - | $40.71 M(-11.5%) |
| Dec 2003 | $145.95 M(+60.2%) | $46.03 M(+27.4%) |
| Sep 2003 | - | $36.14 M(+4.9%) |
| Jun 2003 | - | $34.45 M(+17.4%) |
| Mar 2003 | - | $29.34 M(+26.0%) |
| Dec 2002 | $91.11 M(+24.1%) | $23.28 M(-11.5%) |
| Sep 2002 | - | $26.29 M(+25.5%) |
| Jun 2002 | - | $20.95 M(+1.7%) |
| Mar 2002 | - | $20.59 M(+8.4%) |
| Dec 2001 | $73.40 M(-12.0%) | $18.99 M(+2.2%) |
| Sep 2001 | - | $18.58 M(+3.6%) |
| Jun 2001 | - | $17.93 M(+0.3%) |
| Mar 2001 | - | $17.87 M(-45.1%) |
| Dec 2000 | $83.37 M(+50.9%) | $32.58 M(+85.1%) |
| Sep 2000 | - | $17.60 M(+7.2%) |
| Jun 2000 | - | $16.41 M(+11.9%) |
| Mar 2000 | - | $14.67 M(+0.8%) |
| Dec 1999 | $55.26 M(+74.1%) | $14.56 M(-1.6%) |
| Sep 1999 | - | $14.80 M(-14.9%) |
| Jun 1999 | - | $17.40 M(+104.7%) |
| Mar 1999 | - | $8.50 M(+4.4%) |
| Dec 1998 | $31.74 M(-5.8%) | $8.14 M(+8.5%) |
| Sep 1998 | - | $7.50 M(-6.3%) |
| Jun 1998 | - | $8.00 M(-2.4%) |
| Mar 1998 | - | $8.20 M(-43.1%) |
| Dec 1997 | $33.70 M(+49.1%) | $14.40 M(+111.8%) |
| Sep 1997 | - | $6.80 M(-1.4%) |
| Jun 1997 | - | $6.90 M(+25.5%) |
| Mar 1997 | - | $5.50 M(-14.1%) |
| Dec 1996 | $22.60 M(+39.5%) | $6.40 M(+16.4%) |
| Sep 1996 | - | $5.50 M(-1.8%) |
| Jun 1996 | - | $5.60 M(+12.0%) |
| Mar 1996 | - | $5.00 M(-5.7%) |
| Dec 1995 | $16.20 M | $5.30 M(+32.5%) |
| Sep 1995 | - | $4.00 M |
FAQ
- What is Integra LifeSciences Holdings annual total expenses?
- What is the all time high annual total expenses for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual total expenses year-on-year change?
- What is Integra LifeSciences Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly total expenses year-on-year change?
What is Integra LifeSciences Holdings annual total expenses?
The current annual total expenses of IART is $1.43 B
What is the all time high annual total expenses for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual total expenses is $1.43 B
What is Integra LifeSciences Holdings annual total expenses year-on-year change?
Over the past year, IART annual total expenses has changed by +$111.30 M (+8.44%)
What is Integra LifeSciences Holdings quarterly total expenses?
The current quarterly total expenses of IART is $388.98 M
What is the all time high quarterly total expenses for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly total expenses is $421.20 M
What is Integra LifeSciences Holdings quarterly total expenses year-on-year change?
Over the past year, IART quarterly total expenses has changed by +$33.16 M (+9.32%)